China Healthcare Weekly (Jun.22) - CNPGC to Acquire Shuanglin, Thoughts on Zhou Liu Fu's IPO Pricing
CNPGC plan to acquire Pacific Shuanglin, bringing new M&A/privatization due to horizontal competition. Zhou Liu Fu's IPO is fairly priced, but...
The Impact of Trump's Tariffs on China Healthcare - The Victims, And the Safe Haven Assets
As tariff war is heating up, some sectors in China healthcare will be victims, but there will also safe haven assets.The logic behind tariffs is to...
Tiantan (600161CH) To Acquire Weiguang (002880CH)- New King Rises in China's Blood Products Industry
The change of Weiguang's actual controller will bring about a series of restructuring.As SOE reform enters new stage, investors will have good...
No more insights